Hippocampal Glutamate and Positive Symptom Severity in Clinical High Risk for Psychosis.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 34964821.
- Also identified by DOI 10.1001/jamapsychiatry.2021.3710 and PMC identifier 8717208.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study examines the association between increased hippocampal glutamate and higher total positive symptom severity in converters to psychosis.
Medical subject headings
- Glutamic Acid
- Hippocampus
- Psychotic Disorders